Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Unknown 1Recruiting 1Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 7Neoplasms 3Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neurofibromatosis 1 1Multiple Endocrine Neoplasia Type 1 1Mental Disorders 1Depression 1Caregiver Burden 1Brain Neoplasms 1

Interventions

Therapeutics 21Psychiatric Rehabilitation 20Surveys and Questionnaires 7Early Intervention, Educational 6Counseling 6Yoga 5Psychosocial Intervention 5Cognitive Behavioral Therapy 5Behavior Therapy 5Mindfulness 4Ketamine 4Exercise 4Escitalopram 4Acupuncture Therapy 4Saline Solution 3Psilocybin 3Mindfulness-Based Stress Reduction 3Mindfulness-Based Cognitive Therapy 3Methods 3Exercise Therapy 3Control Groups 3Citalopram 3Chemotherapy, Adjuvant 3Sugars 2Sertraline 2Palliative Care 2Observation 2Niacin 2Mental Status and Dementia Tests 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Depression × Methylphenidate × Clear all
NCT00129467 2015-04-24

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

VA Office of Research and Development

Phase NA Completed
47 enrolled 13 charts

Caregiver Burden, Mental Disorders, Depression, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡